Medicare Wastage Rebate Exceptions For Small Volume Products, Cell/Gene Therapy Urged
Executive Summary
Packaging for such products reflects ‘unique circumstances’ that should exempt them from the rebates on discarded drugs otherwise required by the policy, stakeholders tell CMS at a ‘town hall’ forum.